# Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA

> **NCT06591351** · PHASE3 · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 870 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Cilostazol 100 MG
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT06591351
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-10
- **Target enrollment:** 870 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06591351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06591351, "Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT06591351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*